|
EXP002401
|
Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide…
|
2016 |
Transportan–LyP-1 (tandem peptide)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002402
|
Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide…
|
2016 |
Transportan–LyP-1 (tandem peptide)
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP002403
|
Guanidinylated Cyclic Synthetic Polypeptides Can Effectively Deliver siRNA by M…
|
2021 |
GCSP (guanidinylated cyclic synthetic polypeptide)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002404
|
Targeting the 19S proteasomal subunit, Rpt4, for the treatment of colon cancer
|
2016 |
R8 (Octa-arginine)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002405
|
Targeting the 19S proteasomal subunit, Rpt4, for the treatment of colon cancer
|
2016 |
R8 (Octa-arginine)
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002406
|
Peptide Nanocarriers for Targeted Delivery of Nucleic Acids for Cancer Therapy
|
2025 |
P
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002407
|
Peptide Nanocarriers for Targeted Delivery of Nucleic Acids for Cancer Therapy
|
2025 |
PRGD
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002408
|
Peptide Nanocarriers for Targeted Delivery of Nucleic Acids for Cancer Therapy
|
2025 |
PGRD
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002409
|
Crotamine/siRNA Nanocomplexes for Functional Downregulation of Syndecan-1 in Re…
|
2023 |
Crotamine
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002410
|
Crotamine/siRNA Nanocomplexes for Functional Downregulation of Syndecan-1 in Re…
|
2023 |
Crotamine
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002411
|
Blood pressure reduction through brain delivery of nanoparticles loaded with pl…
|
2024 |
Penetratin
|
pDNA
|
yes |
yes |
|
no |
no |
|
EXP002412
|
Blood pressure reduction through brain delivery of nanoparticles loaded with pl…
|
2024 |
Penetratin
|
pDNA
|
yes |
|
|
yes |
yes |
|
EXP002413
|
Delivery of siRNA to the brain using a combination of nose-to-brain delivery an…
|
2013 |
Tat
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002414
|
Delivery of siRNA to the brain using a combination of nose-to-brain delivery an…
|
2013 |
Tat
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP002415
|
Cell-Penetrating Peptides and Peptide Nucleic Acid-Coupled MRI Contrast Agents:…
|
2009 |
D-Tat57-49 / D-Tatinv
|
ASO
|
yes |
no |
no |
no |
no |
|
EXP002416
|
Cell-Penetrating Peptides and Peptide Nucleic Acid-Coupled MRI Contrast Agents:…
|
2009 |
D-Tat57-49 / D-Tatinv
|
ASO
|
yes |
no |
no |
no |
no |
|
EXP002417
|
Cell-Penetrating Peptides and Peptide Nucleic Acid-Coupled MRI Contrast Agents:…
|
2009 |
D-Tat57-49 / D-Tatinv
|
ASO
|
no |
|
|
yes |
no |
|
EXP002418
|
Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of t…
|
2017 |
RGD-targeted Au PENP / Bcl-2 siRNA polyplex
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002419
|
Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of t…
|
2017 |
RGD-targeted Au PENP / Bcl-2 siRNA polyplex
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002420
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6R-LNP / Cas9 mRNA + sgPten
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002421
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
3R-LNP / Cas9 mRNA + sgPcsk9
|
mRNA
|
yes |
|
|
yes |
yes |
|
EXP002422
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6R-LNP / Cas9 mRNA + sgPten
|
mRNA
|
yes |
|
|
yes |
yes |
|
EXP002423
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6D-LNP / Cas9 mRNA + sgPten
|
mRNA
|
yes |
|
|
yes |
yes |
|
EXP002424
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
3R-LNP / Cas9 mRNA + sgPcsk9
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002425
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6R-LNP / Cas9 mRNA + sgPten
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002426
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6D-LNP / Cas9 mRNA + sgPten
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002427
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
3R-LNP / Cas9 mRNA + sgPcsk9
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002428
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6R-LNP / Cas9 mRNA + sgPten
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002429
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6D-LNP / Cas9 mRNA + sgPten
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002430
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
3R-LNP / Cas9 mRNA + sgPcsk9
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002431
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6R-LNP / Cas9 mRNA + sgPten
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002432
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6D-LNP / Cas9 mRNA + sgPten
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002433
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
3R-LNP / Cas9 mRNA + sgPcsk9
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002434
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6R-LNP / Cas9 mRNA + sgPten
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002435
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
6D-LNP / Cas9 mRNA + sgPten
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002436
|
Peptide codes for organ-selective mRNA delivery
|
2026 |
3R-LNP / Cas9 mRNA + sgPcsk9
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002437
|
Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameli…
|
2019 |
C2-9r
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002438
|
Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameli…
|
2019 |
ApoB11-9R
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002439
|
Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameli…
|
2019 |
C2-9r
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002440
|
Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameli…
|
2019 |
ApoB11-9R
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP002441
|
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate…
|
2025 |
Pip6a-PMO 186
|
SCO
|
no |
yes |
|
no |
no |
|
EXP002442
|
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate…
|
2025 |
B-PMO 186
|
SCO
|
no |
yes |
|
no |
no |
|
EXP002443
|
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate…
|
2025 |
Pip6a-PMO 186
|
SCO
|
no |
yes |
|
no |
no |
|
EXP002444
|
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate…
|
2025 |
Pip6a-PMO 186
|
SCO
|
no |
yes |
|
no |
no |
|
EXP002445
|
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate…
|
2025 |
Pip6a-PMO 186
|
SCO
|
no |
|
|
yes |
yes |
|
EXP002446
|
Lung Delivery Studies Using siRNA Conjugated to TAT(48-60) and Penetratin Revea…
|
2007 |
TAT(48-60)-siRNA
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002447
|
Lung Delivery Studies Using siRNA Conjugated to TAT(48-60) and Penetratin Revea…
|
2007 |
Penetratin-siRNA
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002448
|
Lung Delivery Studies Using siRNA Conjugated to TAT(48-60) and Penetratin Revea…
|
2007 |
TAT(48-60)-siRNA
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP002449
|
Lung Delivery Studies Using siRNA Conjugated to TAT(48-60) and Penetratin Revea…
|
2007 |
Penetratin-siRNA
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP002450
|
Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for …
|
2013 |
Tat48–60 / sihsp90α complex + 17-AAG
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002451
|
Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for …
|
2013 |
Tat48–60 / sihsp90α complex + 17-AAG
|
siRNA
|
no |
yes |
|
no |
no |
|
EXP002452
|
Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for …
|
2013 |
Tat48–60 / sihsp90α complex + 17-AAG
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002453
|
Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mi…
|
2024 |
RGD-decorated liposome / dipalmitoyl-GRGDSPA
|
miRNA
|
no |
yes |
|
no |
no |
|
EXP002454
|
Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mi…
|
2024 |
RGD-decorated liposome / dipalmitoyl-GRGDSPA
|
miRNA
|
no |
|
|
yes |
yes |
|
EXP002455
|
Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using …
|
2020 |
T7 peptide-decorated exosome
|
anti-miRNA
|
yes |
yes |
|
no |
no |
|
EXP002456
|
Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using …
|
2020 |
T7 peptide-decorated exosome
|
anti-miRNA
|
yes |
|
|
yes |
yes |
|
EXP002457
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
MPGDNLS cell-penetrating peptide
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002458
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
CADY cell-penetrating peptide
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002459
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
MPGDNLS cell-penetrating peptide
|
siRNA
|
no |
|
|
yes |
no |
|
EXP002460
|
Controlling fibrous capsule formation through long-term down-regulation of coll…
|
2013 |
CADY cell-penetrating peptide
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002461
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
eGLP-1-C / FOXO1 ASO 3b
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002462
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
eGLP-1-C / FOXO1 ASO 3b
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002463
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
hGLP1(7-36)-C / MALAT1 ASO 26
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002464
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
Exenatide-C / MALAT1 ASO 27
|
ASO
|
yes |
no |
|
no |
no |
|
EXP002465
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
eGLP-1-C / FOXO1 ASO 3b
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002466
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
eGLP-1-C / FOXO1 ASO 3b
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002467
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
hGLP1(7-36)-C / MALAT1 ASO 26
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002468
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
Exenatide-C / MALAT1 ASO 27
|
ASO
|
no |
|
|
yes |
no |
|
EXP002469
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
eGLP-1-C / FOXO1 ASO 3b
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002470
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
eGLP-1-C / FOXO1 ASO 3b
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002471
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
eGLP-1-C / FOXO1 ASO 3b
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002472
|
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Ol…
|
2021 |
eGLP-1-C / FOXO1 ASO 3b
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002473
|
PEGylation of the GALA Peptide Enhances the Lung-Targeting Activity of Nanocarr…
|
2017 |
GALA/PEG2000-MENDssPalmE / anti-CD31 siRNA
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002474
|
Dual Strategies Based on Golgi Apparatus/Endoplasmic Reticulum Targeting and An…
|
2025 |
KDEL-grafted chondroitin sulfate CPD/siBcl-2/CK
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002475
|
Dual Strategies Based on Golgi Apparatus/Endoplasmic Reticulum Targeting and An…
|
2025 |
KDEL-grafted chondroitin sulfate CPD/siBcl-2/CK
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002476
|
Dual Strategies Based on Golgi Apparatus/Endoplasmic Reticulum Targeting and An…
|
2025 |
KDEL-grafted chondroitin sulfate CPD/siBcl-2/CK
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002477
|
Dual Strategies Based on Golgi Apparatus/Endoplasmic Reticulum Targeting and An…
|
2025 |
KDEL-grafted chondroitin sulfate CPD/siBcl-2/CK
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002478
|
In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanopa…
|
2021 |
WRAP5
|
siRNA
|
no |
yes |
yes |
no |
no |
|
EXP002479
|
In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanopa…
|
2021 |
WRAP5
|
siRNA
|
yes |
|
yes |
yes |
yes |
|
EXP002480
|
In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanopa…
|
2021 |
WRAP5
|
siRNA
|
yes |
|
yes |
yes |
no |
|
EXP002481
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
22A ApoA1 mimetic peptide A / lipid-ASO ND1
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002482
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
C-terminal GGC 22A ApoA1 mimetic peptide / NNA3
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002483
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
C-terminal GGC 22A ApoA1 mimetic peptide / NNA3
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002484
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
N-terminal GGC 22A ApoA1 mimetic peptide / NNA5
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002485
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
N-terminal GGC 22A ApoA1 mimetic peptide / NNA5
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002486
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
C-terminal GGC 22A ApoA1 mimetic peptide / NNA3
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002487
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
C-terminal GGC 22A ApoA1 mimetic peptide / NNA3
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002488
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
C-terminal GGC 22A ApoA1 mimetic peptide / NNA3
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002489
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
C-terminal GGC 22A ApoA1 mimetic peptide / NNA3
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002490
|
Nanodiscoidal Nucleic Acids for Gene Regulation
|
2023 |
C-terminal GGC 22A ApoA1 mimetic peptide / NNA3
|
ASO
|
yes |
|
|
yes |
yes |
|
EXP002491
|
Delivery System Targeting Hemagglutinin of Influenza Virus A to Facilitate Anti…
|
2017 |
HA-binding peptide HABP / H17
|
ASO
|
yes |
yes |
|
no |
no |
|
EXP002492
|
Delivery System Targeting Hemagglutinin of Influenza Virus A to Facilitate Anti…
|
2017 |
HA-binding peptide HABP / H17
|
ASO
|
yes |
|
|
yes |
yes |
|
EXP002493
|
Delivery System Targeting Hemagglutinin of Influenza Virus A to Facilitate Anti…
|
2017 |
HA-binding peptide HABP / H17
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002494
|
Delivery System Targeting Hemagglutinin of Influenza Virus A to Facilitate Anti…
|
2017 |
HA-binding peptide HABP / H17
|
ASO
|
no |
|
|
yes |
yes |
|
EXP002495
|
A Novel Peptide Nucleic Acid against the Cytidine Monophosphate Kinase of S. au…
|
2019 |
(KFF)3K-L bacterial penetration peptide
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002496
|
A Novel Peptide Nucleic Acid against the Cytidine Monophosphate Kinase of S. au…
|
2019 |
(KFF)3K-L bacterial penetration peptide
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002497
|
A Novel Peptide Nucleic Acid against the Cytidine Monophosphate Kinase of S. au…
|
2019 |
(KFF)3K-L bacterial penetration peptide
|
ASO
|
no |
no |
|
no |
no |
|
EXP002498
|
A Novel Peptide Nucleic Acid against the Cytidine Monophosphate Kinase of S. au…
|
2019 |
(KFF)3K-L bacterial penetration peptide
|
ASO
|
no |
no |
|
no |
no |
|
EXP002499
|
A Novel Peptide Nucleic Acid against the Cytidine Monophosphate Kinase of S. au…
|
2019 |
(KFF)3K-L bacterial penetration peptide
|
ASO
|
no |
yes |
|
no |
no |
|
EXP002500
|
A Novel Peptide Nucleic Acid against the Cytidine Monophosphate Kinase of S. au…
|
2019 |
(KFF)3K-L bacterial penetration peptide
|
ASO
|
no |
yes |
|
no |
no |